CLEVAIR HTA

From evidence strategy to submission-ready dossier in one continuous workflow

CLEVAIR-HTA has been built specifically to address EU HTA Regulation 2021/2282 and support the JCA process from evidence strategy to submission-ready dossier in one continuous workflow.

Built for pharma teams that need workflow fit, expert control, and traceable execution across comparator work, evidence operations, drafting, and review.

Built for

Market access / HEOR Regulatory / Medical writing Evidence / SLR Cross-functional HTA delivery

A new chapter for CLEVAIR

CLEVAIR joins the Start it @KBC acceleration programme

We are delighted to announce that CLEVAIR has been selected to join the 12-month Start it @KBC startup acceleration programme.

Being welcomed into Belgium's leading startup accelerator is an exciting milestone for our journey. Start it @KBC is renowned for its founder-centric approach, supporting ambitious, innovative, and scalable startups in accelerating their growth and impact.

The year ahead

Over the coming year, we will benefit from access to a unique ecosystem of mentors, coaches, industry experts, investors, strategic partners, and fellow entrepreneurs.

Learning and founder-led coaching

Networking and market expansion

Business development and strategic partnerships

We are grateful for the trust placed in our vision and look forward to the next chapter of growth, collaboration, and innovation. A big thank you to the Start it @KBC team for the opportunity.

We can't wait to get started.

#Startit@KBC #Startup #Innovation #AI #HealthTech #DigitalHealth #Entrepreneurship #ScaleUp #Belgium

Why this matters now

EU HTA Regulation 2021/2282 creates an execution challenge, not just a document challenge

The regulation was meant to streamline assessment. For many teams, it is creating a new execution challenge instead: more coordination pressure across evidence, drafting, review, and delivery.

Comparator logic can shift late and create preventable rework.

Evidence strategy, drafting, and review often remain disconnected.

Teams need acceleration that still protects traceability and expert judgment.

Why CLEVAIR

Built specifically for EU HTA and JCA execution

CLEVAIR-HTA helps teams keep comparator logic, evidence, drafting, and review connected from early strategy through submission-ready output.

Keep comparator logic, evidence, drafting, and review connected in one execution model.

Reduce downstream rework by carrying decisions forward instead of rebuilding the story by hand.

Make ownership, comments, and approvals visible throughout review.

Move validated evidence into submission-ready output without losing traceability.

Days from strategy to value

< 90

Days for readiness assessment

3-5

JCA workflow stages

Annex B AI assistants

Why teams trust CLEVAIR

Move faster without losing control, traceability, or review discipline

Pharma teams trust CLEVAIR when the workflow is transparent, the review process is visible, and the evidence stays traceable throughout.

Request a demo

See whether CLEVAIR fits your current HTA workflow

Show us where your team is facing delay, duplication, comparator complexity, evidence pressure, or review friction. We will tailor the discussion around the part of your workflow that needs the most support first.

Request a tailored demo